Eli Lilly Sues Peptide Vendor

Maybe the pharma suppliers will go a step too far and have the entire situation involving pricing and availability blow up in their face. As long as GLP-1 peptides remain a drug that stands to improve the lives of many people excepting the fact that they are priced out of reach for 95% of the people alongside the supply issues, this could result in a massive PR loss to the extent that we can collectively pressure our government representatives to step in and make proven price gouging a legitimate reason to approve compounding. These companies need to be looked on with the same level of public disdain as Pharma Bro as they are not operating differently.
 

Trending content

Forum statistics

Threads
1,720
Messages
26,881
Members
3,295
Latest member
Linz527
Back
Top